x min read

Stock Beat: Sears Holdings Corp (NASDAQ:SHLD), Vanguard Natural Resources, LLC (NASDAQ:VNR), Advaxis, Inc. (NASDAQ:ADXS)

Stock Beat: Sears Holdings Corp (NASDAQ:SHLD), Vanguard Natural Resources, LLC (NASDAQ:VNR), Advaxis, Inc. (NASDAQ:ADXS)
Written by
Joel Najarian
Published on
October 15, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Sears Holdings Corp (NASDAQ:SHLD) said Ronald D. Boire, executive vice president, chief merchandising officer and president of Sears Full Line Stores and Kmart Format, will be leaving the retailer to become acting president and CEO of its Canadian counterpart, Sears Canada (SCC.TO). At Sears Canada, Boire succeeds Douglas C. Campbell, who announced his resignation as the company's President and CEO last month, and has agreed to work with Boire on the transition through to the end of the year. Sears Canada noted Campbell is returning to the U.S. "to focus on family matters." Sears Canada said it is continuing its search for a permanent successor to Campbell, and called Boire "a leading candidate in that process." Sears Holdings earlier this month said it plans to sell the bulk of the 51% stake it holds in Sears Canada to its own shareholders. Sears Holdings Corp (NASDAQ:SHLD) trades in a 52-week range of $24.10 to $67.50.Vanguard Natural Resources, LLC (NASDAQ:VNR) said its board of directors has approved a $10 million common unit buyback program, initially for a three-month period, to help support the share price amid current oil-counter-related declines. "Companies in the energy sector as a whole and particularly the upstream MLP space have experienced large declines in stock price within the last 30 days in tandem with declines in crude oil prices," said Executive Vice-President & CFO, Richard A. Robert. Vanguard Natural Resources, LLC (NASDAQ:VNR) units are down about 24% over the past 30 days. The company also outlined its hedging strategy for the next three years to protect its cash flow and maintain its monthly distribution, which currently yield 11.4% on an annualized basis. The units closed Tuesday at $22.04 and have a 52-week range of $19.00 - $33.04.Advaxis, Inc. (NASDAQ:ADXS) a biotechnology company developing cancer immunotherapies, reported preliminary data from its Phase 1/2 study of ADXS-HPV in human papillomavirus (HPV)-associated anal cancer. The data indicate a "clinical complete response" in all 7 patients who completed the treatment. The study of 25 patients was designed to determine the safety and effectiveness of ADXS-HPV when combined with chemotherapy and radiation in patients with high risk of recurrence. The primary efficacy objective of the study is to assess the proportion of patients maintaining a clinical complete response at the six-month mark. The addition of ADXS-HPV will be considered promising if the six- month complete response rate is greater than 80%. At present, 7 of 8 patients enrolled are without evidence of disease. Shares of Advaxis, Inc. (NASDAQ:ADXS) are at $2.56 within a 52-week range of $2.46 - $5.99.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.